# Intravenous Clarithromycin in Septic Syndrome

> **NCT00297674** · PHASE4 · COMPLETED · sponsor: **University of Athens** · enrollment: 200 (—)

## Conditions studied

- Sepsis
- Ventilator Associated Pneumonia

## Interventions

- **DRUG:** Intravenous Clarithromycin

## Key facts

- **NCT ID:** NCT00297674
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 200 (—)
- **Last updated:** 2006-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297674, "Intravenous Clarithromycin in Septic Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00297674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*